IL17A and Autoimmunity: Consequently, Reg1+/− mice show exacerbated signs of autoimmunity in multiple IL-17-driven autoimmune conditions, including experimental autoimmune encephalomyelitis (EAE), imiquimod (IMQ)-induced dermatitis, and autoantibody-induced glomerulonephritis (AGN).